Gene Therapy Process Development Summit

2 years ago Posted By : User Ref No: WURUR160586 0
  • Image
  • TypeConference
  • Image
  • Location Philadelphia, Pennsylvania, United States
  • Price
  • Date 13-12-2023 - 14-12-2023
Gene Therapy Process Development Summit, Philadelphia, Pennsylvania, United States
Conference Title
Gene Therapy Process Development Summit
Event Type
Conference
Conference Date
13-12-2023 to 14-12-2023
Location
Philadelphia, Pennsylvania, United States
Organization Name / Organize By
Hanson Wade
Organizing/Related Departments
Hanson Wade
Organization Type
Event Organizing Company
ConferenceCategory
Non Technical
ConferenceLevel
All (State/Province/Region, National & International)
Related Industries

Research/Science

Location
Philadelphia, Pennsylvania, United States

Gene therapy developers are striving to platform their process development to more quickly and cost-effectively bring their drugs to market, meaning optimizing upstream process development has never been a greater priority for this community.

The first Gene Therapy Process Development is your only specific gene therapy event with optimizing process development with the transgene at the forefront of mind.

Join your biopharma colleagues from the likes of Ultragenyx, Janssen, REGENXBIO and more, for two days of cutting-edge talks on cell-line development, scale-up, transfection, purification, analytics, and regulation. This must-attend meeting is your chance to share ideas, successes, and challenges, and capitalize on the latest advances in process development to bring safe and effective drugs to patients faster.

 

Speakers: Brad Mickey, Executive Director, Manufacturing and Operations Site Head, Astellas Gene Therapies, David McNally, Head of Viral Vector Technology, University of Massachusetts Chan Medical School, Gary Todd, VP - Head of Technologies, Lacerta Therapeutics, Huiren Zhao, Principal Scientist, Amgen Inc., Jun Li, Associate Director - Upstream Process Development and Gene Therapy, Ultragenyx, Margaret Liu, Professor at the William G. Lowrie Department of Chemical and Biomolecular Engineering, James Comprehensive Cancer Centre, Oluwatoyin Areo, Research Advisor, Bioassay Development, Ping Liu, Associate Director and Head of Cell Line Development, REGENXBIO, Po-Yi Ho, Senior Scientist, Analytical Development, Carbon Biosciences, Pranav Joshi, Associate Director - Upstream Process Development, Gene Therapy Program at The University of Pennsylvania, Scott Burger, Principal Consultant, Advanced Cell and Gene Therapy, Seema Bhatlekar, Gene Therapy and Process Development Scientist, Janssen, Steve Greenway, Associate Director - Upstream Process Development, Vesigen Therapeutics, Vincent Wiegmann, Upstream Process Development Senior Scientist I, MeiraGTx, Yi Pu, Group Head, Prime Medicine

Others Details

Brochure: https://go.evvnt.com/1943329-3?pid=6581

Registration Fees
Available
Registration Fees Details
Drug Developer Pricing - 2-Day Conference: USD 2999.00, Solution Provider Pricing - 2-Day Conference: USD 3799.00
Registration Ways
Website
Address/Venue
Le Meridien Philadelphia  1421 Arch Street  Pin/Zip Code : 19102
Contact
Rachel McMahon

[email protected]

     +44 (0)20 3141 8700